Professor Chris Twelves, clinical director at the Leeds Teaching Hospitals NHS Trust NIHR Leeds CRF and Professor of Clinical Cancer Pharmacology and Oncology at the University of Leeds said: “This investigational cancer vaccine works by training the immune system to fight the cancer, which could be transformational for patients by slowing spread of the cancer and hopefully controlling their disease for longer.
Trending
- How Will Ropeginterferon Alfa’s Approval Impact Essential Thrombocythemia?
- ‘I have chronic cancer but I’m not going to die’ – BBC presenter Maryam Moshiri
- Enzymatic skeletal editing reaction forming the 1,3,5-triazine core during biosynthesis of the anticancer nucleoside analogue 5-azacytidine
- Real-World Evidence and Meta-Analysis of Chemoimmunotherapy Utilization
- Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs
- BBC News presenter Maryam Moshiri reveals she has incurable blood cancer | Cancer
- Chemo hair loss doesn't define me
- As assisted dying bill returns to Commons, families recall loved ones’ battle to ‘go out on own terms’ | Assisted dying
Monday, September 7
